Financhill
Sell
31

ADCT Quote, Financials, Valuation and Earnings

Last price:
$3.11
Seasonality move :
-27.31%
Day range:
$3.04 - $3.33
52-week range:
$1.05 - $4.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.14x
P/B ratio:
--
Volume:
1.6M
Avg. volume:
903K
1-year change:
-24.19%
Market cap:
$301.5M
Revenue:
$70.8M
EPS (TTM):
-$1.45

Earnings Data

Next earnings date for ADCT
Aug 06
2025
Most recent earnings per share
-$0.36
Missed by $0.36
(May 14/2025)
Consensus Estimate
--
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADCT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $18.3M -- -- -- --
08/06/2025 Q2 $17.9M -- -- -- --
05/14/2025 Q1 $17.7M $23M -$0.36 -- --
03/27/2025 Q4 $19M $16.9M -$0.29 -- --
11/07/2024 Q3 $18.5M $18.5M -$0.42 -- --
08/06/2024 Q2 $18.8M $17.4M -$0.38 -- --
05/06/2024 Q1 $18.1M $18.1M -$0.56 -- --
03/13/2024 Q4 $15.3M $16.8M -$1.04 -- --
11/07/2023 Q3 $15.2M $14.5M -$0.57 -- --
08/08/2023 Q2 $20.1M $19.3M -$0.60 -- --
05/09/2023 Q1 $20.1M $19M -$0.73 -- --
02/28/2023 Q4 $65.5M $69.8M -$0.30 -$0.05 -$0.25
11/08/2022 Q3 -- $76.3M -$0.65 -- --
08/09/2022 Q2 -- $17.3M -$0.84 -- --
05/09/2022 Q1 -- $46.5M -$0.22 -- --
03/03/2022 Q4 -- $17M -$0.45 -- --
11/02/2021 Q3 -- $13.1M -$0.93 -- --
08/03/2021 Q2 -- $3.8M -$0.95 -- --
05/06/2021 Q1 -- -- -$0.67 -- --
03/18/2021 Q4 -- -- -$0.73 -- --
11/12/2020 Q3 -- -- -$0.29 -- --
08/18/2020 Q2 -- -- -$2.01 -- --
03/31/2020 Q1 -- -- -$0.59 -- --
12/31/2019 Q4 -- -- -$0.48 -- --
09/30/2019 Q3 -- -- -$0.43 -- --
06/30/2019 Q2 -- $2M -$0.32 -- --

ADC Therapeutics SA Earnings Questions

  • How Much did ADC Therapeutics SA Generate in Revenue Last Quarter?

    ADC Therapeutics SA reported $23M worth of top line sales in its most recent quarter.

  • Did ADC Therapeutics SA Beat Earnings Last Quarter?

    ADC Therapeutics SA announced earnings per share of -$0.36 which represents a miss of analyst forecast a -- per share.

  • Is ADC Therapeutics SA Profitable?

    ADC Therapeutics SA reported $21M that represents $0.20 per share over the last quarter.

  • What is the Analyst Consensus for ADC Therapeutics SA EPS Next Year?

    ADC Therapeutics SA's earnings are forecast to decrease from -$1.62 per share to -$1.84 per share next year representing a decrease of -50.25%.

  • When is ADC Therapeutics SA's Earnings Date?

    ADC Therapeutics SA's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock